Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
01 mars 2021 19h15 HE | Curium
Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by...
LOGO.jpg
Vivos Inc Extends it Intellectual Property Protection
01 déc. 2020 09h30 HE | Vivos Inc.
Richland WA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it received the Patent Cooperation Treaty (PCT) International Search Report on our patent...
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
08 sept. 2020 13h52 HE | Curium
Houston, TX and St. Louis, MO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that DetectnetTM (copper Cu 64 dotatate injection) was approved by...
Cytovia.png
Hebrew University to Collaborate with Cytovia Therapeutics
18 mars 2020 09h00 HE | Cytovia Therapeutics
NEW YORK and JERUSALEM, March 18, 2020 (GLOBE NEWSWIRE) -- Yissum, the technology transfer company of The Hebrew University of Jerusalem and Cytovia Therapeutics, Inc, a biopharmaceutical company...
provectus_logo.jpg
US FDA GRANTS PV-10 ORPHAN DRUG DESIGNATION FOR NEUROBLASTOMA
05 nov. 2018 08h00 HE | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company was granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA)...
provectus_logo.jpg
PROVECTUS ANNOUNCES PRESENTATION OF PHASE 1 TRIAL OF PV-10 FOR TREATMENT OF SYMPTOMATIC NEUROENDOCRINE TUMORS METASTATIC TO LIVER AT ESMO 2018 CONGRESS
23 oct. 2018 09h00 HE | Provectus Biopharmaceuticals Inc.
- First cohort of 6 patients enrolled and treated; currently recruiting patients into second cohort KNOXVILLE, TN, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that...
energias.jpg
Embolization Coil reduced risks and cost-effectiveness, to witness a CAGR of 4.7% during 2017-2023
07 nov. 2017 08h56 HE | Energias Market Research
NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- The global embolization coil market is expected to witness a CAGR of 4.7%, and is projected to reach USD 1,003.7 Million by 2023. Factors propelling the...
Elsevier Publishes Neural Data Science: A Primer with MATLAB(R) and Python(TM)
29 mars 2017 04h00 HE | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - March 29, 2017) - Elsevier, the information analytics company specializing in science and health, today announced the publication of Neural Data Science: A Primer with...
Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients
05 nov. 2015 15h18 HE | ARUP Laboratories
SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...
The Shadow of Colon Cancer; Lynch Syndrome
17 mars 2015 14h22 HE | ARUP Laboratories
SALT LAKE CITY, March 17, 2015 (GLOBE NEWSWIRE) -- This March, watch your back or more specifically, your colon. Schedule a colonoscopy this month—it's Colorectal/Colon Cancer Awareness Month...